CB2 Insights Inc. (CSE:CBII,Forum) is advancing its business through a new collaboration with the first Colombian cannabis company to be fully licensed in research, cultivation, extraction, distribution and export - licensed producer FCM Global.
For more on this partnership, click here.
The medical cannabis Company recently released its Q3 2019 financial resultsand reported record revenue of $4.2 million (CAD) with sequential growth of 29%.
FULL DISCLOSURE: CB2 Insights Inc. is a client of Stockhouse Publishing.